Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine

被引:20
|
作者
von Hunolstein, C [1 ]
Teloni, R [1 ]
Mariotti, S [1 ]
Recchia, S [1 ]
Orefici, G [1 ]
Nisini, R [1 ]
机构
[1] Ist Super Sanita, Batteriol & Micol Med Lab, I-00161 Rome, Italy
关键词
Hib conjugate vaccine; immunostimulatory sequences; polysaccharide; type 1 immune response;
D O I
10.1093/intimm/12.3.295
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Synthetic oligodeoxynucleotides containing CpG motifs [immunostimulatory sequences (ISS)] have been described as potent adjuvants of type 1 immune responses when co-administered with protein or peptide vaccines. To investigate their role in the immune response to polysaccharides (CHO), different preparations of anti-Haemophilus influenzae type b (Hib) conjugate vaccine were administered to mice. The unconjugated CHO did not induce the synthesis of specific antibodies even in the presence of ISS. On the other hand, anti-CHO-specific antibodies significantly increased in the presence of ISS, when tetanus (TT) or diphtheria [cross-reacting material (CRM)] toxoid-conjugated CHO were used to immunize mice. The adjuvant effect was also observed for the immune response against the carrier protein (TT and CRM), ISS insured an early and long-lasting specific IgG production. The effects of ISS on the anti-CHO immune response could be attributed to the amplification of the T help provided by the carrier. The analysis of anti-CHO IgG subclasses showed a significant increase of IgG2a and IgG3 in the presence of ISS, ISS caused a rapid release of IL-12 and IFN-gamma in sera from treated mice. This data provide a first evidence for the ability of ISS to induce an anti-CHO type 1-like immune response and demonstrate that ISS have the potential to increase host antibody response against both the CHO and the protein component of a conjugated vaccine.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 50 条
  • [31] Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine
    Panpitpat, C
    Thisyakorn, U
    Chotpitayasunondh, T
    Fürer, E
    Que, JU
    Hasler, T
    Cryz, SJ
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2000, 78 (03) : 364 - 371
  • [32] Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera term B subunit conjugate vaccine
    Shen, XZ
    Lagergård, T
    Yang, YH
    Lindblad, M
    Fredriksson, M
    Holmgren, J
    INFECTION AND IMMUNITY, 2000, 68 (10) : 5749 - 5755
  • [33] ANTIBODY PERSISTENCE 4 YEARS AFTER PRIMARY IMMUNIZATION OF INFANTS AND TODDLERS WITH HAEMOPHILUS-INFLUENZAE TYPE-B CRM197 CONJUGATE VACCINE
    ROTHSTEIN, EP
    MADORE, DV
    LONG, SS
    JOURNAL OF PEDIATRICS, 1991, 119 (04): : 655 - 657
  • [34] High performance anion exchange chromatographic and colorimetric methods for quality assessment of total and free polysaccharide content in Haemophilus influenzae type b conjugate vaccine containing lactose
    Hussein, Asmaa R.
    Rezk, Mamdouh R.
    Fathalla, Faten Abdel Aziz
    El-Saharty, Yasser S.
    Nadim, Ahmed H.
    ANALYTICAL METHODS, 2022, 14 (38) : 3757 - 3765
  • [35] The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination
    Goldblatt, D
    Richmond, P
    Millard, E
    Thornton, C
    Miller, E
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02): : 538 - 541
  • [36] PERSISTENCE OF ANTIBODY AND RESPONSE TO BOOSTER DOSE OF HAEMOPHILUS-INFLUENZAE TYPE B POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE VACCINE IN INFANTS IMMUNIZED AT 9 TO 15 MONTHS OF AGE
    LEPOW, M
    RANDOLPH, M
    CIMMA, R
    LARSEN, D
    ROGAN, M
    SCHUMACHER, J
    LENT, B
    GAINTNER, S
    SAMUELSON, J
    GORDON, L
    JOURNAL OF PEDIATRICS, 1986, 108 (06): : 882 - 886
  • [37] ANTIBODY PERSISTENCE 4 YEARS AFTER PRIMARY IMMUNIZATION OF INFANTS AND TODDLERS WITH HAEMOPHILUS-INFLUENZAE TYPE-B CRM187 (HBOC) CONJUGATE VACCINE
    ROTHSTEIN, EP
    MADORE, DV
    BERNSTEIN, HH
    SCHILLER, RP
    GIRONE, JAC
    HIPP, TJ
    SOUDER, RL
    SCHIFFMAN, MS
    KENNEDY, TI
    LONG, SS
    PEDIATRIC RESEARCH, 1991, 29 (04) : A183 - A183
  • [38] Immunity to Haemophilus influenzae type b polysaccharide capsule after vaccination with the complete series of oligosaccharide CRM(197) conjugate vaccine in infants with human immunodeficiency virus infection
    Peters, VB
    Sood, SK
    JOURNAL OF PEDIATRICS, 1996, 128 (03): : 363 - 365
  • [39] THE IMMUNE-RESPONSE OF INFANTS TO HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINE, HBOC, IS INDEPENDENT OF PREEXISTING MATERNAL ANTIBODIES TO DIPHTHERIA-TOXIN
    MADORE, DV
    CIMINO, C
    HAWTHORNE, J
    HILDRETH, N
    HOGERMAN, D
    HACKELL, J
    PARADISO, P
    PEDIATRIC RESEARCH, 1995, 37 (04) : A182 - A182
  • [40] ANTI-POLYRIBOSYLRIBITOL PHOSPHATE ANTIBODY-LEVELS 5 YEARS AFTER A PRIMARY SERIES OF HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINE
    WALTER, EB
    SIMMONS, SS
    CLEMENTS, DA
    JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (04): : 1050 - 1051